ArticleChinese journal of integrative medicine2026
Qingda Granule and Its Individual Herbs Inhibit Hypertension-Induced Vascular Smooth Muscle Cells Proliferation via ERK and JNK Pathways.
Article in Chinese journal of integrative medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate the specific role and underlying mechanisms of individual herbs in Qingda Granule (QDG) in attenuating hypertension and inhibiting proliferation of vascular smooth muscle cells (VSMCs).
methodsSpontaneously hypertensive rats (SHRs) and angiotensin II (Ang II)-stimulated VSMCs were treated with QDG or its individual herbs. SHRs were divided into groups using a completely randomized design: SHRs, valsartan (Val), QDG, Gastrodia elata Blume (Tianma, Gas), Uncaria rhynchophylla Miz. ex Havil. (Gouteng, Unc), Scutellaria baicalensis Georgi (Huangqin, Scu), and Nelumbo nucifera Gaertn (Lianzixin, Nel), 6 in each group. All treatments were administered via intragastric gavage once daily for 10 weeks. Vascular function and pathological changes were evaluated by ultrasonography and HE staining. The proliferation of VSMCs was assayed by cell counting kit-8, immunohistochemistry (IHC), and Western blot. RNA sequencing was performed to identify differentially expressed transcripts (DETs) in the abdominal aorta. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis was performed to identify the key signaling pathways, and the expression of pathway-related proteins was subsequently verified by IHC and Western blot.
resultsQDG and its individual herb treatments significantly attenuated the increase in pulse wave velocity and aortic wall thickness in SHRs. QDG inhibited the increased PCNA expression and cell viability in VSMCs. Unc, Scu, and Nel exhibited effects similar to QDG, while Gas did not show these effects. RNA sequencing analysis identified DETs in abdominal aortic tissues. KEGG analysis based on the DETs revealed that multiple common and unique signaling pathways were enriched. Among them, the MAPK pathway was enriched in the QDG, Unc, Scu, and Nel groups, but not in the Gas group, and the cAMP pathway was significantly enriched in all groups. IHC and Western blot analysis verified that compared with the SHR group, the QDG, Unc, Scu, and Nel groups inhibited MAPK pathway activation and promoted cAMP pathway activation in the abdominal aorta of SHR and Ang II-stimulated A7R5s (P<0.05). However, Gas only inhibited the activation of the p38 MAPK pathway and promoted the activation of the cAMP pathway (P<0.05).
conclusionsThe herbs in QDG exert significant antihypertensive effects by regulating common and unique pathways. Specifically, Unc, Scu, and Nel inhibit ERK and JNK pathway activation, which likely underlies QDG's suppression of VSMCs proliferation.
Indexed as
Identifiers
42536295What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.